Atalanta Sosnoff Capital’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $274K | Buy |
7,125
+210
| +3% | +$8.06K | 0.01% | 96 |
|
|
2025
Q1 | $268K | Buy |
6,915
+791
| +13% | +$30.6K | 0.01% | 97 |
|
|
2024
Q4 | $207K | Buy |
6,124
+445
| +8% | +$15.1K | ﹤0.01% | 97 |
|
|
2024
Q3 | $232K | Hold |
5,679
| – | – | 0.01% | 100 |
|
|
2024
Q2 | $219K | Sell |
5,679
-218
| -4% | -$8.39K | ﹤0.01% | 88 |
|
|
2024
Q1 | $253K | Buy |
+5,897
| New | +$253K | 0.01% | 96 |
|
|
2015
Q3 | – | Sell |
-4,168
| Closed | -$217K | – | 99 |
|
|
2015
Q2 | $217K | Buy |
+4,168
| New | +$217K | 0.01% | 98 |
|